Résistance aux antibiotiques chez les pneumocoques

Revue Medicale de la Suisse Romande

Volumn 120, Issue 8, 2000, Pages 651-659

  Moreillon, Philippe ^a   Wenger, Aline ^a   Caldelari, Isabelle ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PNEUMOCOCCUS VACCINE;

ADULT; CHILD; CLASSIFICATION; DRUG EFFECT; EPIDEMIOLOGY; HUMAN; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATIENT SELECTION; PENICILLIN RESISTANCE; PHYSIOLOGY; PREVALENCE; REVIEW; SEROTYPING; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; EPIDEMIOLOGY, MOLECULAR; HUMANS; MICROBIAL SENSITIVITY TESTS; PATIENT SELECTION; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0034244612     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Musher D.M.: Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis., 14: 801-809, 1992.
2. Pallares R., Linares J., Vadillo M., Cabellos C., Manresa F. et al.: Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med., 333: 474-480, 1995.
3. Klugman K.P.: Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev., 3: 171-196, 1990.
4. Appelbaum P.C.: Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis., 15: 77-83, 1992.
5. Griffith F.: The significance of pneumococcal types. J. Hyg. (London), 27: 113-159, 1928.
6. Avery O.T., MacLeod C.M., McCarty M.: Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribunocleic acid fraction isolated from Pneumococcus Type III. J. Exp. Med., 79: 137-158, 1944.
7. Crick F.H.C., Barnett L., Brenner S., Watts-Tobin R.J.: General nature of the genetic code for proteins. Nature, 192: 1227-1232, 1961.
8. Tomasz A.: The mechanisms of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria. Annu. Rev. Microbiol., 33: 113-137, 1979.
9. Moreillon P., Tomasz A.: Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. J. Infect. Dis., 157: 1150-1157, 1988.
10. Liu H.H., Tomasz A.: Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J. Infect. Dis., 152: 365-372, 1985.
11. Garcia-Bustos J.F., Tomasz A.: A biological price for antibiotic resistance: major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc. Natl. Acad. Sci. USA, 87: 5415-5419, 1990.
12. Potgieter E., Chalkley L.J.: Relatedness among penicillin-binding protein 2b genes of Streptococcus mitis, Streptococcus oralis, and Streptococcus pneumoniae. Microb. Drug. Res., 1: 35-42, 1995.
13. Dowson C.G., Coffey T.J., Spratt B.G.: Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics. Trends Microbiol., 2: 361-366, 1995.
14. Hansman D., Bullen M.M.: A resistant pneumococcus. Lancet, ii: 264-265, 1967.
15. Jacobs M.R., Koornhof H.J., Robins-Browne R.M., Stevenson C.M., Vermaak Z.A. et al.: Emergence of multiply resistant pneumococci. N. Engl. J. Med., 293: 735-740, 1978.
16. Appelbaum P.C.: World-wide development of antibiotic resistance in pneumococci. Eur. J. Clin. Microbiol., 6: 367-377, 1987.
17. Guillemot D., Carbon C., Balkau B., Geslin P., Lecoeur H., Vauzelle-Kervroëdan F., Bouvenot G., Eschwege E.: Low dosage and long treatment duration of beta-lactam. Risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA, 279 (5): 365-370, 1998.
18. Kristinsson K.G.: Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Res., 3 (2): 117-123, 1997.
19. Figueiredo A.M.S., Austrian R., Urbaskova P., Teixeira L.A., Tomasz A.: Novel penicillin-resistant clones of Streptococcus pneumoniae in the Czech Republic and in Slovakia. Microb. Drug. Res., 1: 71-78, 1995.
20. Soares S., Kristinsson K.G., Musser J.M., Tomasz A.: Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. J. Infect. Dis., 168: 158-163, 1993.
21. Coffey T.J., Dowson C.G., Daniels M., Spratt B.G.: Genetics and molecular biology of beta-lactam-resistant pneumococci. Microb. Drug. Res., 1: 29-34, 1995.
22. Coffey T.J., Dowson C.G., Daniels M., Zhou J., Martin C. et al.: Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol. Microbiol. 5: 2255-2260, 1991.
23. Dagan R., Melamed R., Muallem M., Piglansky L., Greenberg D., Abramson O., Mendelman P.M., Bohidar N., Yagupsky P.: Reduction of nasopharyngeal carnage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J. Infect. Dis., 174: 1271-1278, 1996.
24. Fenoll A., Jado I., Vicioso D., Perez A., Casai J.: Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: Update (1990-1996). J. Clin. Microbiol., 36 (12): 3447-3454, 1998.
25. Marton A.: Pneumococcal antimicrobial resistance: the problem in Hungary. Clin. Infect. Dis., 15: 106-111, 1992.
26. Vaz Pato M.V., Belo do Carvalho C., Tomasz A., the Multicenter Study. Group: Antibiotic susceptibility of Streptococcus pneumoniae isolates in Portugal. A multicenter study between 1989 and 1993. Microb. Drug Res., 1: 59-69, 1995.
27. Geslin P., Fremaux A., Sissa G.: Mise au point du Centre national de Référence. Med. Mal. Infect., special issue: 3-11, 1991.
28. Pradier C., Dunais B., Carsenti-Etesse H., Dellamonica P.: Pneumococcal resistance patterns in Europe. Eur. J. Clin. Microbiol. Infect. Dis., 16 (9): 644-647, 1997.
29. Lister P.D.: Multiply-resistant pneumococcus: therapeutic problems in the management of serious infections. Eur. J. Clin. Microbiol. Infect. Dis., 14 (suppl.1): 18-25, 1995.
30. Figueiredo A.M.S., Connor J.D., Severin A., Vaz Pato M.V., Tomasz A.: A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob. Agents Chemother., 36: 886-889, 1992.
31. Dabernat H., Geslin P., Megraud F., Begue P., Boulesteix J., Dubreuil C. et al.: Study of nasopharyngeal carnage and effects of two antibiotics on potential pathogens in children with acute otitis media. Abstracts of the 35th Interscience conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington. D.C. 1995, 40.
32. Setchanova L.: Clinical isolates and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in hospital for infectious diseases, Sofia, Bulgaria, 1991-1993. Microb. Drug. Res., 1: 79-84, 1995.
33. Sutcliffe J., Tait-Kamradt A., Wondrack L.: Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother., 40: 1817-1824, 1996.
34. Perrez-Trallero E., Urbieta M., Montes M., Ayestaran I., Marimon J.M.: Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzka, Spain. Eur. J. Clin. Microbiol. Infect. Dis., 16: 25-31, 1998.
35. Davies T.A., Pankuch G.A., Dewasse B.E., Jabobs M.R., Appelbaum P.C.: In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae. Antimicrob. Agents Chemother., 43 (5): 1177-1182, 1999.
36. Lipsitch M.: Bacterial vaccines and serotpype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg. Infect. Dis., 5 (3): 336-345, 1999.